VIE/DMP (VIE/DMP)

Vienna Stock Exchange: VIE/DMP · EUR

€38.5

+0.25 (+0.7%)· Recorded snapshot

Market cap	1.9B
Revenue (ttm)	1.2B
Net income (ttm)	146.5M
EPS (ttm)	€2.77
P/E (trailing)	13.9x
P/E (forward)	13.0x
Dividend	€0.88 (2.29%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2B
Net income (ttm): 146.5M
EPS (ttm): €2.77
P/E (trailing): 13.9x
P/E (forward): 13.0x
Market cap: 1.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E13

P25 14.3P50 18.7P75 25.4

Trailing P/E13.9

P25 20.4P50 26.7P75 39.7

ROE25.6

P25 4.8P50 10.6P75 20.1

ROIC12.3

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/DMP indicators

Market & fundamental data

Available fields

223

Groups with data

Currency

EUR

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-11-12
Employees	3,619
Employees change	-59
Employees growth	-1.63%
Enterprise value	EUR 2.9B
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1991
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	DE000A2GS5D8
Last earnings date	2026-08-11
Last refreshed	2026-10-29
Market cap	EUR 1.9B
Next earnings date	2026-11-12
Price	EUR 38.50
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	vie/DMP
Website	https://ir.dermapharm.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	21.93x
Average P/E ratio (3Y)	20.96x
Average P/E ratio (5Y)	19.55x
Earnings yield	7.2%
EV/Earnings	19.53x
EV/EBIT	11.34x
EV/EBITDA	8.93x
EV/FCF	13.25x
EV/Sales	2.42x
FCF / EV yield	7.55%
FCF yield	11.41%
Forward P/E	12.95x
Graham number	26.96788
Graham upside	-29.95%
Lynch fair value	EUR 14.91
Lynch upside	-61.28%
P/B ratio	3.55x
P/E ratio	13.89x
P/FCF ratio	8.76x
P/OCF ratio	7.16x
P/S ratio	1.6x
Price/EBITDA ratio	6.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	21.06%
EBITDA margin	26.19%
Effective tax rate	24.5%
FCF margin	18.27%
Gross margin	65.41%
Operating margin	21.06%
Pretax margin	16.3%
Profit margin	12.39%
Profit per employee	EUR 40,491
Profitable quarters	10
Profitable years	11
Revenue per employee	EUR 326,697
ROA	7.11%
ROA (5Y)	9.36%
ROCE	13.86%
ROE	25.57%
ROE (5Y)	25.44%
ROIC	12.31%
ROIC (5Y)	14.77%
Tax / revenue	3.99%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	39.03%
EPS growth (Q)	20.51%
EPS growth (QoQ)	-44.05%
EPS growth 3Y	6.63%
EPS growth 5Y	3.99%
EPS growth quarters	5
EPS growth years	2
FCF growth	23.16%
FCF growth (Q)	-44.89%
FCF growth (QoQ)	-36.29%
FCF growth 3Y	-6.86%
FCF growth 5Y	13.46%
Gross profit growth	4.2%
Gross profit growth (Q)	6.66%
Gross profit growth 3Y	3.21%
Gross profit growth 5Y	9.01%
Net income growth	36.7%
Net income growth (Q)	11.15%
Net income growth (QoQ)	-48.62%
Net income growth 3Y	6.14%
Net income growth 5Y	3.51%
Net income growth quarters	5
Net income growth years	2
OCF growth	22.66%
OCF growth (Q)	-30.95%
OCF growth (QoQ)	-23.93%
OCF growth 3Y	-4.58%
OCF growth 5Y	9.99%
Operating income growth	8.31%
Operating income growth (Q)	15.62%
Operating income growth 3Y	-0.82%
Operating income growth 5Y	6.54%
Revenue growth	0.4%
Revenue growth (Q)	4.78%
Revenue growth (QoQ)	-6.75%
Revenue growth 3Y	1.34%
Revenue growth 5Y	6.97%
Revenue growth quarters	3
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -48.4M
Depreciation and amortization	EUR 60.6M
EBIT	EUR 249M
EBITDA	EUR 309.6M
EPS	EUR 2.77
Financing cash flow	EUR -131.3M
Free cash flow	EUR 216M
Gross profit	EUR 773.4M
Income taxes	EUR 47.2M
Investing cash flow	EUR -101M
Net borrowing	EUR 148.5M
Net cash flow	EUR 32.9M
Net income	EUR 146.5M
Operating income	EUR 249M
Revenue	EUR 1.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.01
Book value per share	EUR 10.86
Debt / EBITDA	3.69
Debt / equity	2.19
Debt / FCF	5.41
Goodwill	EUR 587.1M
Interest coverage	5.48
Long-term assets	EUR 1.5B
Long-term liabilities	EUR 1.3B
Net cash (debt)	EUR -973.4M
Net cash / market cap	-51.44%
Net debt / EBITDA	3.14
Net debt / equity	1.83
Net debt / FCF	4.51
Piotroski F-Score	5
Property, plant and equipment	EUR 331.9M
Shareholders' equity	EUR 533M
Tangible book value	EUR -542.3M
Tangible book value per share	EUR -10.97
Total assets	EUR 2.2B
Total cash	EUR 195.6M
Total debt	EUR 1.2B
Total liabilities	EUR 1.7B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current assets	EUR 763.5M
Current liabilities	EUR 445.9M
Current ratio	1.71
Inventory turnover	1.13
Net working capital	EUR 261.2M
Quick ratio	0.75
Working capital	EUR 317.6M
Working capital turnover	3.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.68%
Dividend growth	-2.22%
Dividend growth years	1
Dividend payment date	2026-07-01
Dividend payment years	3
Dividend payout frequency	Annual
Dividend per share	EUR 0.88
Dividend yield	2.29%
Ex-dividend date	2026-06-29
Last dividend	EUR 0.88
Payout ratio	33.07%
Shareholder yield	3.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 43.14
1D price change	0.65%
1M price change	-1.79%
1M total return	-1.79%
1W price change	1.05%
1W total return	1.05%
1Y price change	16.84%
1Y return CAGR	19.05%
1Y total return	19.04%
20-day SMA	EUR 38.41
200-day SMA	EUR 41.93
3M price change	-6.21%
3M total return	-6.21%
50-day SMA	EUR 38.83
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 51.20
52-week high date	2026-05-18
52-week low	EUR 32.50
52-week low date	2025-10-28
6M price change	-15.85%
6M total return	-14.27%
All-time high	EUR 51.20
All-time high date	2026-05-18
All-time low	EUR 30.60
All-time low date	2024-10-31
Average true range (ATR)	EUR 0.48
Average volume	0
Change from 52-week high	-24.8%
Change from 52-week low	18.46%
Change from all-time high	-24.8%
Change from all-time low	25.82%
Change from open	0.52%
Day's gap	0.13%
High price	EUR 38.50
Low price	EUR 38.30
Monthly RSI	51.55
Open price	EUR 38.30
Position in 52-week range	100%
Previous close	EUR 38.25
Price vs 150-day SMA	-10.76%
Price vs 20-day SMA	0.24%
Price vs 200-day SMA	-8.18%
Price vs 50-day SMA	-0.85%
Relative volume	6.67
RSI	48.91
Sharpe ratio	0.66
Sortino ratio	1.3
Weekly RSI	42.13
YTD price change	-1.16%
YTD total return	0.7%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6.5M
Shares change (QoQ)	-8.17%
Shares change (YoY)	-1.68%
Shares held by insiders	0.52%
Shares held by institutions	7.7%

Deeper analysis on VIE/DMP

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/DMP report

Is a complete VIE/DMP research report available?

No complete published report is available for vie/DMP (VIE/DMP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/DMP (VIE/DMP)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/DMP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/DMP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/DMP

Frequently asked questions